Vaš brskalnik ne omogoča JavaScript!
JavaScript je nujen za pravilno delovanje teh spletnih strani. Omogočite JavaScript ali pa uporabite sodobnejši brskalnik.
Repozitorij Univerze v Ljubljani
Nacionalni portal odprte znanosti
Odprta znanost
DiKUL
slv
|
eng
Iskanje
Napredno
Novo v RUL
Kaj je RUL
V številkah
Pomoč
Prijava
Podrobno
Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma
ID
Chikhaoui, Asma
(
Avtor
),
ID
Režen, Tadeja
(
Avtor
),
ID
Komel, Radovan
(
Avtor
),
ID
Yacoub-Youssef, Houda
(
Avtor
), et al.
PDF - Predstavitvena datoteka,
prenos
(3,20 MB)
MD5: BADE9F89E3A3B764542B40329D2F5B85
URL - Izvorni URL, za dostop obiščite
https://www.nature.com/articles/s41598-022-17928-z
Galerija slik
Izvleček
Xeroderma pigmentosum (XP) is a DNA repair disease that predisposes to early skin cancers as cutaneous melanoma. Melanoma microenvironment contains inflammatory mediators, which would be interesting biomarkers for the prognosis or for the identification of novel therapeutic targets. We used a PCR array to evaluate the transcriptional pattern of 84 inflammatory genes in melanoma tumors obtained from XP patients (XP‑Mel) and in sporadic melanoma (SP‑Mel) compared to healthy skin. Commonly expressed inflammatory genes were further explored via GTEx and GEPIA databases. The differentially expressed inflammatory genes in XP were compared to their expression in skin exposed to UVs, and evaluated on the basis of the overall survival outcomes of patients with melanoma. Monocyte subsets of patients with SP‑Mel, XP and healthy donors were also assessed. PCR array data revealed that 34 inflammatory genes were under‑expressed in XP‑Mel compared to SP‑Mel. Differentially expressed genes that were common in XP‑Mel and SP‑Mel were correlated with the transcriptomic datasets from GEPIA and GTEx and highlighted the implication of KLK1 and IL8 in the tumorigenesis. We showed also that in XP‑Mel tumors, there was an overexpression of KLK6 and KLK10 genes, which seems to be associated with a bad survival rate. As for the innate immunity, we observed a decrease of intermediate monocytes in patients with SP‑Mel and in XP. We highlight an alteration in the immune response in XP patients. We identified candidate biomarkers involved in the tumorigenesis, and in the survival of patients with melanoma. Intermediate monocyte’s in patients at risk could be a prognostic biomarker for melanoma outcome.
Jezik:
Angleški jezik
Ključne besede:
xeroderma pigmentosum
,
cutaneous melanoma
,
inflammatory mediators
,
biomarkers
,
melanoma
,
monocytes and macrophages
,
nucleotide excision repair
Vrsta gradiva:
Članek v reviji
Tipologija:
1.01 - Izvirni znanstveni članek
Organizacija:
MF - Medicinska fakulteta
Status publikacije:
Objavljeno
Različica publikacije:
Objavljena publikacija
Leto izida:
2022
Št. strani:
13 str.
Številčenje:
Vol. 12, art. 13854
PID:
20.500.12556/RUL-165904
UDK:
616-006
ISSN pri članku:
2045-2322
DOI:
10.1038/s41598-022-17928-z
COBISS.SI-ID:
121891075
Datum objave v RUL:
13.12.2024
Število ogledov:
373
Število prenosov:
176
Metapodatki:
Citiraj gradivo
Navadno besedilo
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Kopiraj citat
Objavi na:
Gradivo je del revije
Naslov:
Scientific reports
Skrajšan naslov:
Sci. rep.
Založnik:
Nature Publishing Group
ISSN:
2045-2322
COBISS.SI-ID:
18727432
Licence
Licenca:
CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:
http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:
To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Sekundarni jezik
Jezik:
Slovenski jezik
Ključne besede:
xeroderma pigmentosum
,
kožni melanom
,
vnetni mediatorji
Projekti
Financer:
Tunisia, Ministry of Public Health
Financer:
Tunisia, Ministry of Higher Education and Scientific Research
Številka projekta:
LR16IPT05
Financer:
IPT
Program financ.:
Projet Collaborative Interne
Akronim:
PCI_Melanoma
Financer:
ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:
P1-0104
Naslov:
Funkcijska genomika in biotehnologija za zdravje
Financer:
ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:
P1-0390
Naslov:
Funkcijska genomika in biotehnologija za zdravje
Podobna dela
Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:
Nazaj